T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone-Reference-Cited by-同舟云学术

T cells of patients with myelodysplastic syndrome are frequently derived from the malignant clone

Published:2011-09-21 Issue:3 Volume:156 Page:409-412
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Vercauteren Suzanne M.,Starczynowski Daniel T.,Sung Sandy,McNeil Kelly,Salski Chris,Jensen Clara-Lynn,Bruyere Helene,Lam Wan L.,Karsan Aly

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.08872.x/fullpdf

Reference10 articles.

1. Resolving the resolution of array CGH;Coe;Genomics,2007

2. Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology;Disperati;Leukemia Research,2006

3. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936;van Dongen;Leukemia,2003

4. Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome;Epling-Burnette;Leukemia,2007

5. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage;van Lom;Leukemia,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System;Onco Zine - The International Oncology Network;2024-04-19

2. Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine;Clinical Cancer Research;2022-10-12

3. Inflammation and myeloid malignancy: quenching the flame;Blood;2022-09-08

4. Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia;Blood Cancer Discovery;2022-05-06

5. From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review;Diagnostics;2021-10-26